Olopatadine
Overview
Categories
- 21 Ophthalmological preparations
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Olopatadine's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 2.22 to 0 mg/ml | 1.1 (1.11) | 24 hourly | opthalmic | The dose is one drop of olopatadine in the conjunctival sac of the affected eye(s) twice daily (8 hourly). Treatment may be maintained for up to four months, if considered necessary. |
Paedriatic Dosage (20kg)
|
| 2.22 to 0 mg/ml | 1.1 (1.11) | 24 hourly | opthalmic | The dose is one drop of olopatadine in the conjunctival sac of the affected eye(s) twice daily (8 hourly). Treatment may be maintained for up to four months, if considered necessary. |
Neonatal Dosage (3kg)
|
| 2.22 to 0 mg/ml | 1.1 (1.11) | 24 hourly | opthalmic | The dose is one drop of olopatadine in the conjunctival sac of the affected eye(s) twice daily (8 hourly). Treatment may be maintained for up to four months, if considered necessary. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Olopatadine
Back to top
Previous Drug Generic - Next Drug Generic